{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T01:27:19Z","timestamp":1774747639919,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T00:00:00Z","timestamp":1614038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18dm0107134"],"award-info":[{"award-number":["JP18dm0107134"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Molecular Autism"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Oxytocin is expected as a novel therapeutic agent for autism spectrum disorder (ASD) core symptoms. However, previous results on the efficacy of repeated administrations of oxytocin are controversial. Recently, we reported time-course changes in the efficacy of the neuropeptide underlying the controversial effects of repeated administration; however, the underlying mechanisms remained unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The current study explored metabolites representing the molecular mechanisms of oxytocin\u2019s efficacy using high-throughput metabolomics analysis on plasma collected before and after 6-week repeated intranasal administration of oxytocin (48\u00a0IU\/day) or placebo in adult males with ASD (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009106) who participated in a multi-center, parallel-group, double-blind, placebo-controlled, randomized controlled trial.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 35 metabolites measured, a significant increase in\n                      <jats:italic>N<\/jats:italic>\n                      ,\n                      <jats:italic>N<\/jats:italic>\n                      -dimethylglycine was detected in the subjects administered oxytocin compared with those given placebo at a medium effect size (false discovery rate (FDR) corrected\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.043,\n                      <jats:italic>d<\/jats:italic>\n                      \u2009=\u20090.74,\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200983). Furthermore, subgroup analyses of the participants displaying a prominent time-course change in oxytocin efficacy revealed a significant effect of oxytocin on\n                      <jats:italic>N<\/jats:italic>\n                      ,\n                      <jats:italic>N<\/jats:italic>\n                      -dimethylglycine levels with a large effect size (\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>FDR<\/jats:sub>\n                      \u2009=\u20090.004,\n                      <jats:italic>d<\/jats:italic>\n                      \u2009=\u20091.13,\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200960). The increase in\n                      <jats:italic>N<\/jats:italic>\n                      ,\n                      <jats:italic>N<\/jats:italic>\n                      -dimethylglycine was significantly correlated with oxytocin-induced clinical changes, assessed as changes in quantifiable characteristics of autistic facial expression, including both of improvements between baseline and 2\u00a0weeks (\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>FDR<\/jats:sub>\n                      \u2009=\u20090.006,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.485,\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200943) and deteriorations between 2 and 4\u00a0weeks (\n                      <jats:italic>P<\/jats:italic>\n                      <jats:sub>FDR<\/jats:sub>\n                      \u2009=\u20090.032,\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.415,\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u200937).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Limitations<\/jats:title>\n                    <jats:p>The metabolites changes caused by oxytocin administration were quantified using peripheral blood and therefore may not directly reflect central nervous system changes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Our findings demonstrate an association of\n                      <jats:italic>N<\/jats:italic>\n                      ,\n                      <jats:italic>N<\/jats:italic>\n                      -dimethylglycine upregulation with the time-course change in the efficacy of oxytocin on autistic social deficits. Furthermore, the current findings support the involvement of the\n                      <jats:italic>N<\/jats:italic>\n                      -methyl-D-aspartate receptor and neural plasticity to the time-course change in oxytocin\u2019s efficacy.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      : A multi-center, parallel-group, placebo-controlled, double-blind, confirmatory trial of intranasal oxytocin in participants with autism spectrum disorders (the date registered: 30 October 2014; UMIN Clinical Trials Registry:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000017703\">https:\/\/upload.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000017703<\/jats:ext-link>\n                      ) (UMIN000015264).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13229-021-00423-z","type":"journal-article","created":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T08:03:23Z","timestamp":1614067403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms"],"prefix":"10.1186","volume":"12","author":[{"given":"Yasuhiko","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Munesue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seico","family":"Benner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walid","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Eriguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Kameno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Murayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoto","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2748-6317","authenticated-orcid":false,"given":"Hidenori","family":"Yamasue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"423_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/WCO.0000000000000703","volume":"32","author":"H Yamasue","year":"2019","unstructured":"Yamasue H, Aran A, Berry-Kravis E. Emerging pharmacological therapies in fragile X syndrome and autism. Curr Opin Neurol. 2019;32:635\u201340.","journal-title":"Curr Opin Neurol"},{"key":"423_CR2","doi-asserted-by":"publisher","first-page":"14109","DOI":"10.1523\/JNEUROSCI.3327-12.2012","volume":"32","author":"H Yamasue","year":"2012","unstructured":"Yamasue H, Yee JR, Yee JR, Hurlemann R, Rilling JK, Chen FS, et al. Integrative approaches utilizing oxytocin to enhance prosocial behavior: from animal and human social behavior to autistic social dysfunction. J Neurosci. 2012;32:14109\u201317.","journal-title":"J Neurosci"},{"key":"423_CR3","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1093\/brain\/awu231","volume":"137","author":"Y Aoki","year":"2014","unstructured":"Aoki Y, Yahata N, Watanabe T, Takano Y, Kawakubo Y, Kuwabara H, et al. Oxytocin improves behavioural and neural deficits in inferring others&apos; social emotions in autism. Brain. 2014;137:3073\u201386.","journal-title":"Brain"},{"key":"423_CR4","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1073\/pnas.0910249107","volume":"107","author":"E Andari","year":"2010","unstructured":"Andari E, Andari E, Duhamel J-R, Duhamel J-R, Zalla T, Herbrecht E, et al. Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. Proc Natl Acad Sci USA. 2010;107:4389\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"423_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.biopsych.2013.02.007","volume":"74","author":"G Domes","year":"2013","unstructured":"Domes G, Heinrichs M, Kumbier E, Grossmann A, Hauenstein K, Herpertz SC. Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder. Biol Psychiatry. 2013;74:164\u201371.","journal-title":"Biol Psychiatry"},{"key":"423_CR6","doi-asserted-by":"publisher","first-page":"20953","DOI":"10.1073\/pnas.1312857110","volume":"110","author":"I Gordon","year":"2013","unstructured":"Gordon I, Vander Wyk BC, Bennett RH, Bennett RH, Cordeaux C, Cordeaux C, et al. Oxytocin enhances brain function in children with autism. Proc Natl Acad Sci USA. 2013;110:20953\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"423_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.biopsych.2009.09.020","volume":"67","author":"AJ Guastella","year":"2010","unstructured":"Guastella AJ, Einfeld SL, Gray KM, Rinehart NJ, Tonge BJ, Lambert TJ, et al. Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders. Biol Psychiatry. 2010;67:692\u20134.","journal-title":"Biol Psychiatry"},{"key":"423_CR8","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1001\/jamapsychiatry.2013.3181","volume":"71","author":"T Watanabe","year":"2013","unstructured":"Watanabe T, Abe O, Kuwabara H, Yahata N, Takano Y, Iwashiro N, et al. Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial. JAMA psychiatry. 2013;71:166\u201375.","journal-title":"JAMA psychiatry"},{"key":"423_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/pcn.12364","volume":"70","author":"H Yamasue","year":"2015","unstructured":"Yamasue H. Promising evidence and remaining issues regarding the clinical application of oxytocin in autism spectrum disorders. Psychiatry Clin Neurosci. 2015;70:89\u201399.","journal-title":"Psychiatry Clin Neurosci"},{"key":"423_CR10","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/s41380-018-0249-4","volume":"26","author":"S Benner","year":"2021","unstructured":"Benner S, Aoki Y, Watanabe T, Endo N, Abe O, Kuroda M, et al. Neurochemical evidence for differential effects of acute and repeated oxytocin administration. Mol Psychiatry. 2021;26:710\u201320.","journal-title":"Mol Psychiatry"},{"key":"423_CR11","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1093\/brain\/awz126","volume":"142","author":"K Owada","year":"2019","unstructured":"Owada K, Okada T, Munesue T, Kuroda M, Fujioka T, Uno Y, et al. Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism. Brain. 2019;142:2127\u201336.","journal-title":"Brain"},{"key":"423_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tics.2019.10.004","volume":"24","author":"S Fan","year":"2019","unstructured":"Fan S, Weinberg-Wolf H, Piva M, Dal Monte O, Chang SWC. Combinatorial oxytocin neuropharmacology in social cognition. Trends Cogn Sci. 2019;24:8\u201312.","journal-title":"Trends Cogn Sci"},{"key":"423_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/mp.2014.74","volume":"20","author":"Y Aoki","year":"2015","unstructured":"Aoki Y, Watanabe T, Abe O, Kuwabara H, Yahata N, Takano Y, et al. Oxytocin\u2019s neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial. Mol Psychiatry. 2015;20:447\u201353.","journal-title":"Mol Psychiatry"},{"key":"423_CR14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.psyneuen.2015.07.005","volume":"62","author":"J Mairesse","year":"2015","unstructured":"Mairesse J, Gatta E, Reynaert ML, Marrocco J, Morley-Fletcher S, Soichot M, et al. Activation of presynaptic oxytocin receptors enhances glutamate release in the ventral hippocampus of prenatally restraint stressed rats. Psychoneuroendocrinol. 2015;62:36\u201346.","journal-title":"Psychoneuroendocrinol"},{"key":"423_CR15","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1038\/npp.2015.81","volume":"40","author":"I Mesic","year":"2015","unstructured":"Mesic I, Guzman YF, Guedea AL, Jovasevic V, Corcoran KA, Leaderbrand K, et al. Double dissociation of the roles of metabotropic glutamate receptor 5 and oxytocin receptor in discrete social behaviors. Neuropsychopharmacology. 2015;40:2337\u201346.","journal-title":"Neuropsychopharmacology"},{"key":"423_CR16","doi-asserted-by":"publisher","first-page":"e0190442","DOI":"10.1371\/journal.pone.0190442","volume":"13","author":"K Owada","year":"2018","unstructured":"Owada K, Kojima M, Yassin W, Kuroda M, Kawakubo Y, Kuwabara H, et al. Computer-analyzed facial expression as a surrogate marker for autism spectrum social core symptoms. PLoS ONE. 2018;13:e0190442.","journal-title":"PLoS ONE"},{"key":"423_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/BF02211841","volume":"19","author":"C Lord","year":"1989","unstructured":"Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L, et al. Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord. 1989;19:185\u2013212.","journal-title":"J Autism Dev Disord"},{"key":"423_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13229-016-0083-y","volume":"7","author":"T Fujioka","year":"2016","unstructured":"Fujioka T, Inohara K, Okamoto Y, Masuya Y, Ishitobi M, Saito DN, et al. Gazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adults. Mol Autism. 2016;7:19.","journal-title":"Mol Autism"},{"key":"423_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.biopsych.2012.08.025","volume":"74","author":"KL Bales","year":"2013","unstructured":"Bales KL, Perkeybile AM, Conley OG, Lee MH, Guoynes CD, Downing GM, et al. Chronic intranasal oxytocin causes long-term impairments in partner preference formation in male prairie voles. Biol Psychiatry. 2013;74:180\u20138.","journal-title":"Biol Psychiatry"},{"key":"423_CR20","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.1038\/tp.2014.117","volume":"4","author":"KL Bales","year":"2014","unstructured":"Bales KL, Solomon M, Jacob S, Crawley JN, Silverman JL, Larke RH, et al. Long-term exposure to intranasal oxytocin in a mouse autism model. Transl Psychiatry. 2014;4:e480.","journal-title":"Transl Psychiatry"},{"key":"423_CR21","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1210\/endo.130.5.1315251","volume":"130","author":"TR Insel","year":"1992","unstructured":"Insel TR, Winslow JT, Witt DM. Homologous regulation of brain oxytocin receptors. Endocrinology. 1992;130:2602\u20138.","journal-title":"Endocrinology"},{"key":"423_CR22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.neuroscience.2004.02.028","volume":"125","author":"Y Yamamoto","year":"2004","unstructured":"Yamamoto Y, Cushing BS, Kramer KM, Epperson PD, Hoffman GE, Carter CS. Neonatal manipulations of oxytocin alter expression of oxytocin and vasopressin immunoreactive cells in the paraventricular nucleus of the hypothalamus in a gender-specific manner. Neuroscience. 2004;125:947\u201355.","journal-title":"Neuroscience"},{"key":"423_CR23","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1021\/ac020064n","volume":"74","author":"T Soga","year":"2002","unstructured":"Soga T, Ueno Y, Naraoka H, Ohashi Y, Tomita M, Nishioka T. Simultaneous determination of anionic intermediates for Bacillus subtilis metabolic pathways by capillary electrophoresis electrospray ionization mass spectrometry. Anal Chem. 2002;74:2233\u20139.","journal-title":"Anal Chem"},{"key":"423_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0097-2","author":"H Yamasue","year":"2018","unstructured":"Yamasue H, Okada T, Munesue T, Kuroda M, Fujioka T, Uno Y, et al. Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: a randomized clinical trial. Mol Psychiatry. 2018. https:\/\/doi.org\/10.1038\/s41380-018-0097-2.","journal-title":"Mol Psychiatry"},{"key":"423_CR25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/BF02172145","volume":"24","author":"C Lord","year":"1994","unstructured":"Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24:659\u201385.","journal-title":"J Autism Dev Disord"},{"key":"423_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/0361-476X(81)90035-7","volume":"6","author":"D Wechsler","year":"1981","unstructured":"Wechsler D. The psychometric tradition: developing the Wechsler adult intelligence scale. Contemp Educ Psychol. 1981;6:82\u20135.","journal-title":"Contemp Educ Psychol"},{"key":"423_CR27","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1093\/brain\/awv249","volume":"138","author":"T Watanabe","year":"2015","unstructured":"Watanabe T, Kuroda M, Kuwabara H, Aoki Y, Iwashiro N, Tatsunobu N, et al. Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism. Brain. 2015;138:3400\u201312.","journal-title":"Brain"},{"key":"423_CR28","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1039\/c0mb00141d","volume":"7","author":"T Ooga","year":"2011","unstructured":"Ooga T, Sato H, Nagashima A, Sasaki K, Tomita M, Soga T, et al. Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia. Mol Biosyst. 2011;7:1217\u201323.","journal-title":"Mol Biosyst"},{"key":"423_CR29","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1186\/1471-2105-7-530","volume":"7","author":"R Baran","year":"2006","unstructured":"Baran R, Kochi H, Saito N, Suematsu M, Soga T, Nishioka T, et al. MathDAMP: a package for differential analysis of metabolite profiles. BMC Bioinformatics. 2006;7:530\u20139.","journal-title":"BMC Bioinformatics"},{"key":"423_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1039\/B714176A","volume":"4","author":"Y Ohashi","year":"2008","unstructured":"Ohashi Y, Hirayama A, Ishikawa T, Nakamura S, Shimizu K, Ueno Y, et al. Depiction of metabolome changes in histidine-starved Escherichia coli by CE-TOFMS. Mol Biosyst. 2008;4:135\u201347.","journal-title":"Mol Biosyst"},{"key":"423_CR31","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/00004583-200111000-00009","volume":"40","author":"T Owley","year":"2001","unstructured":"Owley T, McMahon W, Cook EH, Laulhere T, South M, Mays LZ, et al. Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. J Am Acad Child Adolesc Psychiatry. 2001;40:1293\u20139.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"423_CR32","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/j.1469-7610.2004.00338.x","volume":"45","author":"C Aldred","year":"2004","unstructured":"Aldred C, Green J, Adams C, Adams C. A new social communication intervention for children with autism: pilot randomised controlled treatment study suggesting effectiveness. J Child Psychol Psychiatry. 2004;45:1420\u201330.","journal-title":"J Child Psychol Psychiatry"},{"key":"423_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1469-7610.2006.01707.x","volume":"48","author":"P Howlin","year":"2007","unstructured":"Howlin P, Gordon RK, Pasco G, Wade A, Charman T. The effectiveness of Picture Exchange Communication System (PECS) training for teachers of children with autism: a pragmatic, group randomised controlled trial. J Child Psychol Psychiatry. 2007;48:473\u201381.","journal-title":"J Child Psychol Psychiatry"},{"key":"423_CR34","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/S0140-6736(10)60587-9","volume":"375","author":"J Green","year":"2010","unstructured":"Green J, Gotts SJ, Charman T, Simmons WK, McConachie H, Milbury LA, et al. Parent-mediated communication-focused treatment in children with autism (PACT): a randomised controlled trial. Lancet. 2010;375:2152\u201360.","journal-title":"Lancet"},{"key":"423_CR35","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s10803-009-0916-z","volume":"40","author":"VCN Wong","year":"2009","unstructured":"Wong VCN, Kwan QK. Randomized controlled trial for early intervention for autism: a pilot study of the autism 1-2-3 project. J Autism Dev Disord. 2009;40:677\u201388.","journal-title":"J Autism Dev Disord"},{"key":"423_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12991-020-00287-2","volume":"19","author":"T Fujioka","year":"2020","unstructured":"Fujioka T, Fujisawa TX, Inohara K, Okamoto Y, Matsumura Y, Tsuchiya KJ, et al. Attenuated relationship between salivary oxytocin levels and attention to social information in adolescents and adults with autism spectrum disorder: a comparative study. Ann Gen Psychiatry. 2020;19:38\u201313.","journal-title":"Ann Gen Psychiatry"},{"key":"423_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13229-020-00321-w","volume":"11","author":"T Fujioka","year":"2020","unstructured":"Fujioka T, Tsuchiya KJ, Saito M, Hirano Y, Matsuo M, Kikuchi M, et al. Developmental changes in attention to social information from childhood to adolescence in autism spectrum disorders: a comparative study. Mol Autism. 2020;11:24\u201317.","journal-title":"Mol Autism"},{"key":"423_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.schres.2013.05.003","volume":"148","author":"AS Cohen","year":"2013","unstructured":"Cohen AS, Morrison SC, Callaway DA. Computerized facial analysis for understanding constricted\/blunted affect: initial feasibility, reliability, and validity data. Schizophr Res. 2013;148:111\u20136.","journal-title":"Schizophr Res"},{"key":"423_CR39","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1037\/npe0000028","volume":"7","author":"P Lewinski","year":"2014","unstructured":"Lewinski P, den Uyl TM, Butler C. Automated facial coding: Validation of basic emotions and FACS AUs in FaceReader. J Neurosci Psychol Econ. 2014;7:227\u201336.","journal-title":"J Neurosci Psychol Econ"},{"key":"423_CR40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/pcn.12258","volume":"69","author":"H Fujiwara","year":"2015","unstructured":"Fujiwara H, Yassin W, Murai T. Neuroimaging studies of social cognition in schizophrenia. Psychiatry Clin Neurosci. 2015;69:259\u201367.","journal-title":"Psychiatry Clin Neurosci"},{"key":"423_CR41","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1038\/s41598-017-05121-6","volume":"7","author":"H Umehara","year":"2017","unstructured":"Umehara H, Numata S, Watanabe S-Y, Hatakeyama Y, Kinoshita M, Tomioka Y, et al. Altered KYN\/TRP, Gln\/Glu, and Met\/methionine sulfoxide ratios in the blood plasma of medication-free patients with major depressive disorder. Sci Rep. 2017;7:4855\u20138.","journal-title":"Sci Rep"},{"key":"423_CR42","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","volume":"51","author":"RM Baron","year":"1986","unstructured":"Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51:1173\u201382.","journal-title":"J Pers Soc Psychol"},{"key":"423_CR43","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1467-842X.2001.tb00294.x","volume":"25","author":"DA Bennett","year":"2001","unstructured":"Bennett DA. How can I deal with missing data in my study? Aust N Z J Public Health. 2001;25:464\u20139.","journal-title":"Aust N Z J Public Health"},{"issue":"1","key":"423_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/00913847.1982.11947150","volume":"10","author":"ME Gray","year":"1982","unstructured":"Gray ME, Titlow LW. B15: myth or miracle? Phys Sportsmed. 1982;10(1):107\u201312.","journal-title":"Phys Sportsmed"},{"key":"423_CR45","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01186-20","author":"T Yang","year":"2020","unstructured":"Yang T, Shao YH, Guo LZ, Meng XL, Yu H, Lu WD. Role of N,N-dimethylglycine and its catabolism to sarcosine in chromohalobacter salexigens DSM 3043. Appl Environ Microbiol. 2020. https:\/\/doi.org\/10.1128\/AEM.01186-20.","journal-title":"Appl Environ Microbiol."},{"key":"423_CR46","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1111\/j.1742-4658.2008.06515.x","volume":"275","author":"H Wolosker","year":"2008","unstructured":"Wolosker H, Dumin E, Balan L, Foltyn VN. D-amino acids in the brain: D-serine in neurotransmission and neurodegeneration. FEBS J. 2008;275:3514\u201326.","journal-title":"FEBS J"},{"key":"423_CR47","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1113\/jphysiol.2009.168757","volume":"587","author":"HX Zhang","year":"2009","unstructured":"Zhang HX, Hyrc K, Thio LL. The glycine transport inhibitor sarcosine is an NMDA receptor co-agonist that differs from glycine. J Physiol. 2009;587:3207\u201320.","journal-title":"J Physiol"},{"key":"423_CR48","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1176\/appi.ajp.2016.16080868","volume":"173","author":"CI Rodriguez","year":"2016","unstructured":"Rodriguez CI, Zwerling J, Kalanthroff E, Shen H, Filippou M, Jo B, et al. Effect of a novel NMDA receptor modulator, rapastinel (formerly GLYX-13), in OCD: proof of concept. Am J Psychiatry. 2016;173:1239\u201341.","journal-title":"Am J Psychiatry"},{"key":"423_CR49","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nature11208","volume":"486","author":"H Won","year":"2012","unstructured":"Won H, Lee H-R, Gee HY, Mah W, Kim J-I, Lee J, et al. Autistic-like social behaviour in Shank2 -mutant mice improved by restoring NMDA receptor function. Nature. 2012;486:261\u20135.","journal-title":"Nature"},{"key":"423_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1262\/jrd.2015-149","volume":"62","author":"T Takahashi","year":"2016","unstructured":"Takahashi T, Sasaki K, Somfai T, Nagai T, Manabe N, Edashige K. N,N-Dimethylglycine decreases oxidative stress and improves in vitro development of bovine embryos. J Reprod Dev. 2016;62:209\u201312.","journal-title":"J Reprod Dev"},{"key":"423_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/infdis\/143.1.101","volume":"143","author":"CD Graber","year":"1982","unstructured":"Graber CD, Goust JM, Giassman AD, Kendall R, Loadholt CB. Immunomodulating properties of dimethylglycine in humans. J Infect Dis. 1982;143:101\u20135.","journal-title":"J Infect Dis"},{"key":"423_CR52","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/0091-3057(85)90288-6","volume":"22","author":"WJ Freed","year":"1985","unstructured":"Freed WJ. Prevention of strychnine-induced seizures and death by the N-methylated glycine derivatives betaine, dimethylglycine and sarcosine. Pharmacol Biochem Behav. 1985;22:641\u20133.","journal-title":"Pharmacol Biochem Behav"},{"key":"423_CR53","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.pnpbp.2016.06.002","volume":"71","author":"J-C Lin","year":"2016","unstructured":"Lin J-C, Chan M-H, Lee M-Y, Chen Y-C, Chen H-H. N,N-dimethylglycine differentially modulates psychotomimetic and antidepressant-like effects of ketamine in mice. Prog Neuropsychopharmacol Biol Psychiatry. 2016;71:7\u201313.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"423_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2020.152613","author":"CP Hsieh","year":"2020","unstructured":"Hsieh CP, Chen H, Chan MH, Chen L, Chen HH. N,N-dimethylglycine prevents toluene-induced impairment in recognition memory and synaptic plasticity in mice. Toxicology. 2020. https:\/\/doi.org\/10.1016\/j.tox.2020.152613.","journal-title":"Toxicology"},{"key":"423_CR55","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1111\/j.1582-4934.2008.00463.x","volume":"13","author":"SP Pa\u015fca","year":"2009","unstructured":"Pa\u015fca SP, Dronca E, Kaucs\u00e1r T, Craciun EC, Endreffy E, Ferencz BK, et al. One carbon metabolism disturbances and the C677T MTHFR gene polymorphism in children with autism spectrum disorders. J Cell Mol Med. 2009;13:4229\u201338.","journal-title":"J Cell Mol Med"},{"key":"423_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1023\/A:1023023820671","volume":"29","author":"WM Bolman","year":"1999","unstructured":"Bolman WM, Richmond JA. A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder. J Autism Dev Disord. 1999;29:191\u20134.","journal-title":"J Autism Dev Disord"},{"key":"423_CR57","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.braindev.2017.03.029","volume":"39","author":"M Gogou","year":"2017","unstructured":"Gogou M, Kolios G. The effect of dietary supplements on clinical aspects of autism spectrum disorder: a systematic review of the literature. Brain Dev. 2017;39:656\u201364.","journal-title":"Brain Dev"},{"key":"423_CR58","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2310\/7010.2001.17515","volume":"16","author":"JK Kern","year":"2001","unstructured":"Kern JK, Miller VS, Cauller PL, Kendall PR, Mehta PJ, Dodd M. Effectiveness of N,N-dimethylglycine in autism and pervasive developmental disorder. J Child Neurol. 2001;16:169\u201373.","journal-title":"J Child Neurol"},{"key":"423_CR59","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/acm.2010.0146","volume":"17","author":"RR Xia","year":"2011","unstructured":"Xia RR. Effectiveness of nutritional supplements for reducing symptoms in autism-spectrum disorder: a case report. J Altern Complement Med. 2011;17:271\u20134.","journal-title":"J Altern Complement Med"},{"key":"423_CR60","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1159\/000127036","volume":"62","author":"SL Parker","year":"1995","unstructured":"Parker SL, Crowley WR. Central stimulation of oxytocin release in the lactating rat by N-methyl-D-aspartate: requirement for coactivation through non-NMDA glutamate receptors or the glycine coagonist site. Neuroendocrinology. 1995;62:467\u201378.","journal-title":"Neuroendocrinology"},{"key":"423_CR61","first-page":"23","volume":"38","author":"M Orlowska-Majdak","year":"2004","unstructured":"Orlowska-Majdak M. Effect of excitatory amino acids on activity of vasopressinergic and oxytocinergic neurons. Endocr Regul. 2004;38:23\u20138.","journal-title":"Endocr Regul"},{"key":"423_CR62","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12929-016-0314-8","volume":"24","author":"MY Lee","year":"2017","unstructured":"Lee MY, Lin YR, Tu YS, Tseng YJ, Chan MH, Chen HH. Effects of sarcosine and N,N-dimethylglycine on NMDA receptor-mediated excitatory field potentials. J Biomed Sci. 2017;24:18.","journal-title":"J Biomed Sci"},{"key":"423_CR63","doi-asserted-by":"crossref","unstructured":"Vilhena-Franco T, Valentim-Lima E, Reis LC, Elias LLK, Antunes-Rodrigues J, Mecawi AS. Role of AMPA and NMDA receptors on vasopressin and oxytocin secretion induced by hypertonic extracellular volume expansion. J Neuroendocrinol. 2018; e12633.","DOI":"10.1111\/jne.12633"},{"key":"423_CR64","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nn1023","volume":"6","author":"K Tomizawa","year":"2003","unstructured":"Tomizawa K, Iga N, Lu Y-F, Moriwaki A, Matsushita M, Li S-T, et al. Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade. Nat Neurosci. 2003;6:384\u201390.","journal-title":"Nat Neurosci"},{"key":"423_CR65","doi-asserted-by":"publisher","first-page":"e1004402","DOI":"10.1371\/journal.pgen.1004402","volume":"10","author":"ER Berko","year":"2014","unstructured":"Berko ER, Berko ER, Suzuki M, Suzuki M, Beren F, Beren F, et al. Mosaic epigenetic dysregulation of ectodermal cells in autism spectrum disorder. PLoS Genet. 2014;10:e1004402.","journal-title":"PLoS Genet"},{"key":"423_CR66","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/nn.3634","volume":"17","author":"J-J Zheng","year":"2014","unstructured":"Zheng J-J, Zheng J-J, Li S-J, Li S-J, Zhang X-D, Zhang X-D, et al. Oxytocin mediates early experience-dependent cross-modal plasticity in the sensory cortices. Nat Neurosci. 2014;17:391\u20139.","journal-title":"Nat Neurosci"},{"key":"423_CR67","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.biopsych.2018.08.016","volume":"85","author":"AM Smith","year":"2019","unstructured":"Smith AM, King JJ, West PR, Ludwig MA, Donley ELR, Burrier RE, Amaral DG. Amino acid dysregulation metabotypes: potential biomarkers for diagnosis and individualized treatment for subtypes of autism spectrum disorder. Biol Psychiatry. 2019;85:345\u201354.","journal-title":"Biol Psychiatry"},{"key":"423_CR68","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3389\/fpsyt.2019.00647","volume":"10","author":"KE Glinton","year":"2019","unstructured":"Glinton KE, Elsea SH. Untargeted metabolomics for autism spectrum disorders: current status and future directions. Frontiers in Psychiatry. 2019;10:647.","journal-title":"Frontiers in Psychiatry"},{"key":"423_CR69","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/npp.2008.174","volume":"34","author":"R Kaddurah-Daouk","year":"2009","unstructured":"Kaddurah-Daouk R, Krishnan KRR. Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology. 2009;34:173\u201386.","journal-title":"Neuropsychopharmacology"},{"key":"423_CR70","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.npep.2012.07.001","volume":"46","author":"A Gossen","year":"2012","unstructured":"Gossen A, Hahn A, Westphal L, Prinz S, Schultz RT, Gr\u00fcnder G, et al. Oxytocin plasma concentrations after single intranasal oxytocin administration\u2014a study in healthy men. Neuropeptides. 2012;46:211\u20135.","journal-title":"Neuropeptides"},{"key":"423_CR71","doi-asserted-by":"publisher","first-page":"R431","DOI":"10.1152\/ajpregu.00441.2014","volume":"308","author":"JE Blevins","year":"2015","unstructured":"Blevins JE, Graham JL, Morton GJ, Bales KL, Schwartz MW, Baskin DG, et al. Chronic oxytocin administration inhibits food intake, increases energy expenditure, and produces weight loss in fructose-fed obese rhesus monkeys. Am J Physiol Regul Integr Comp Physiol. 2015;308:R431\u20138.","journal-title":"Am J Physiol Regul Integr Comp Physiol"}],"container-title":["Molecular Autism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-021-00423-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13229-021-00423-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-021-00423-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,23]],"date-time":"2021-02-23T08:22:51Z","timestamp":1614068571000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularautism.biomedcentral.com\/articles\/10.1186\/s13229-021-00423-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,23]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["423"],"URL":"https:\/\/doi.org\/10.1186\/s13229-021-00423-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-50529\/v1","asserted-by":"object"}]},"ISSN":["2040-2392"],"issn-type":[{"value":"2040-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,23]]},"assertion":[{"value":"21 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experimental procedures complied with the Declaration of Helsinki and were approved by the institutional review board of Hamamatsu University School of Medicine, The University of Tokyo, Nagoya University, Kanazawa University, and University of Fukui. Participants gave written informed consent before participating in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The funding agency had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. There are no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}